Fatal interstitial lung disease associated with icotinib

The most serious, and maybe fatal, yet rare, adverse reaction of gefitinib and erlotinib is drug-associated interstitial lung disease (ILD), which has been often described. However, it has been less well described for icotinib, a similar orally small-molecule tyrosine kinase inhibitor (TKI). The cas...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Thorac Dis
Huvudupphovsmän: Zhang, Jiexia, Zhan, Yangqing, Ouyang, Ming, Qin, Yinyin, Zhou, Chengzhi, Chen, Rongchang
Materialtyp: Artigo
Språk:Inglês
Publicerad: Pioneer Bioscience Publishing Company 2014
Ämnen:
Case Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4283337/
https://ncbi.nlm.nih.gov/pubmed/25590006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2014.10.24
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk